Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2007 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 163 | 4 | 59 |
| Receivables | N/A | N/A | 295 |
| TOTAL | $163 | $4 | $355 |
| Non-Current Assets | |||
| Investments And Advances | 0 | 0 | 140 |
| Other Non-Current Assets | 23 | 53 | 9 |
| TOTAL | $23 | $53 | $149 |
| Total Assets | $186 | $58 | $503 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 64 | 100 | N/A |
| Accounts payable and accrued liabilities | 406 | 60 | 355 |
| Accrued Expenses | 291 | 382 | 221 |
| Other current liabilities | 100 | N/A | N/A |
| TOTAL | $1,064 | $541 | $576 |
| Non-Current Liabilities | |||
| Deferred Revenues | 203 | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $1,064 | $541 | $576 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 145,863 | 126,555 | N/A |
| Common Shares | 4,560 | 4,202 | 3,378 |
| Retained earnings | -5,438 | -4,685 | -3,452 |
| Other shareholders' equity | 0 | 0 | 2 |
| TOTAL | $-878 | $-483 | $-72 |
| Total Liabilities And Equity | $186 | $58 | $503 |